Rosette-forming glioneuronal tumour of the fourth ventricle. Not always a foreseeable development

4Citations
Citations of this article
14Readers
Mendeley users who have this article in their library.

Abstract

Aim of the study: Rosette-forming glioneuronal tumour (RGNT) of the fourth ventricle is an uncommon tumour. The management is not consensual. Most of the published cases show stable outcome with and without gross total resection and are regarded as having a relatively indolent behaviour. Material and methods: We present a 32-year-old man with a tumour in the fourth ventricle. He underwent midline suboccipital craniectomy with gross total removal. Results: The histopathological diagnosis was RGNT grade I. Four years later he presented a radiological progression and received stereotactic radiosurgery. At the last follow-up seven years after surgery, the MRI showed no recurrence. Conclusions: RGNT should be considered in the differential diagnosis of a posterior fossa tumour and has to be differentiated from other lesions for its indolent course and favourable prognosis. Surgical procedures should be carefully performed to avoid serious surgical morbidities. Stereotactic radiosurgery treatment appears to be a useful treatment in recurrence episodes.

Cite

CITATION STYLE

APA

Ramos, A. A., Vega, I. F., Batista, K. P., Fernandez, V. M., Sanchez, C. R., & Alvarez Vega, M. A. (2018). Rosette-forming glioneuronal tumour of the fourth ventricle. Not always a foreseeable development. Wspolczesna Onkologia, 22(4), 270–274. https://doi.org/10.5114/wo.2018.81750

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free